共 16 条
- [15] Therapeutic effects and associated adverse events of PD-1 and CTLA-4 pathway inhibitors in the treatment of non-small-cell lung cancer: meta-analyses of clinical phase II/III randomized controlled trials INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (01): : 1529 - 1538
- [16] BENEFITS AND RISKS OF USING ERYTHROPOIESIS-STIMULATING AGENTS (ESAS) IN NON-SMALL CELL LUNG CANCER (NSCLC) AND SMALL CELL LUNG CANCER (SCLC) PATIENTS: RESULTS FROM STUDY-LEVEL AND PATIENT-LEVEL META-ANALYSES OF CONTROLLED ESA TRIALS IN LUNG CANCER JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S645 - S646